|
|
Line 3: |
Line 3: |
| <StructureSection load='6u5l' size='340' side='right'caption='[[6u5l]], [[Resolution|resolution]] 1.75Å' scene=''> | | <StructureSection load='6u5l' size='340' side='right'caption='[[6u5l]], [[Resolution|resolution]] 1.75Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[6u5l]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6U5L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6U5L FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6u5l]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6U5L OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6U5L FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=3RJ:N~2~-(1H-BENZIMIDAZOL-6-YL)-N~4~-(5-CYCLOBUTYL-1H-PYRAZOL-3-YL)QUINAZOLINE-2,4-DIAMINE'>3RJ</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.75Å</td></tr> |
- | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">ULK4 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=3RJ:N~2~-(1H-BENZIMIDAZOL-6-YL)-N~4~-(5-CYCLOBUTYL-1H-PYRAZOL-3-YL)QUINAZOLINE-2,4-DIAMINE'>3RJ</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene></td></tr> |
- | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] </span></td></tr>
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6u5l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6u5l OCA], [https://pdbe.org/6u5l PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6u5l RCSB], [https://www.ebi.ac.uk/pdbsum/6u5l PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6u5l ProSAT]</span></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6u5l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6u5l OCA], [http://pdbe.org/6u5l PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6u5l RCSB], [http://www.ebi.ac.uk/pdbsum/6u5l PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6u5l ProSAT]</span></td></tr> | + | |
| </table> | | </table> |
| == Disease == | | == Disease == |
- | [[http://www.uniprot.org/uniprot/ULK4_HUMAN ULK4_HUMAN]] Various anomalies in ULK4 gene have been reported for several cases of schizophrenia, schizophrenia plus bipolar disorder and autism. ULK4 gene has been proposed to be a rare susceptibility risk factor for a range of psychiatric diseases including schizophrenia.<ref>PMID:24284070</ref> | + | [https://www.uniprot.org/uniprot/ULK4_HUMAN ULK4_HUMAN] Various anomalies in ULK4 gene have been reported for several cases of schizophrenia, schizophrenia plus bipolar disorder and autism. ULK4 gene has been proposed to be a rare susceptibility risk factor for a range of psychiatric diseases including schizophrenia.<ref>PMID:24284070</ref> |
| == Function == | | == Function == |
- | [[http://www.uniprot.org/uniprot/ULK4_HUMAN ULK4_HUMAN]] May be involved in the remodeling of cytoskeletal components, such as alpha-tubulin, and in this way regulates neurite branching and elongation, as well as cell motility.<ref>PMID:24284070</ref> | + | [https://www.uniprot.org/uniprot/ULK4_HUMAN ULK4_HUMAN] May be involved in the remodeling of cytoskeletal components, such as alpha-tubulin, and in this way regulates neurite branching and elongation, as well as cell motility.<ref>PMID:24284070</ref> |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 22: |
Line 21: |
| </div> | | </div> |
| <div class="pdbe-citations 6u5l" style="background-color:#fffaf0;"></div> | | <div class="pdbe-citations 6u5l" style="background-color:#fffaf0;"></div> |
| + | |
| + | ==See Also== |
| + | *[[Serine/threonine protein kinase 3D structures|Serine/threonine protein kinase 3D structures]] |
| == References == | | == References == |
| <references/> | | <references/> |
| __TOC__ | | __TOC__ |
| </StructureSection> | | </StructureSection> |
- | [[Category: Human]] | + | [[Category: Homo sapiens]] |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Non-specific serine/threonine protein kinase]]
| + | [[Category: Khamrui S]] |
- | [[Category: Khamrui, S]] | + | [[Category: Lazarus MB]] |
- | [[Category: Lazarus, M B]] | + | |
- | [[Category: Kinase]]
| + | |
- | [[Category: Pseudokinase]]
| + | |
- | [[Category: Transferase]]
| + | |
- | [[Category: Transferase-transferase inhibitor complex]]
| + | |
| Structural highlights
Disease
ULK4_HUMAN Various anomalies in ULK4 gene have been reported for several cases of schizophrenia, schizophrenia plus bipolar disorder and autism. ULK4 gene has been proposed to be a rare susceptibility risk factor for a range of psychiatric diseases including schizophrenia.[1]
Function
ULK4_HUMAN May be involved in the remodeling of cytoskeletal components, such as alpha-tubulin, and in this way regulates neurite branching and elongation, as well as cell motility.[2]
Publication Abstract from PubMed
The ULK (UNC51-like) enzymes are a family of mammalian kinases that have critical roles in autophagy and development. While ULK1, ULK2, and ULK3 have been characterized, very little is known about ULK4. However, recently, deletions in ULK4 have been genetically linked to increased susceptibility to developing schizophrenia, a devastating neuropsychiatric disease with high heritability but few genes identified. Interestingly, ULK4 is a pseudokinase with some unusual mutations in the kinase catalytic motifs. Here, we report the first structure of the human ULK4 kinase at high resolution and show that although ULK4 has no apparent phosphotransfer activity, it can strongly bind ATP. We find an unusual mechanism for binding ATP in a Mg(2+)-independent manner, including a rare hydrophobic bridge in the active site. In addition, we develop two assays for ATP binding to ULK4, perform a virtual and experimental screen to identify small-molecule binders of ULK4, and identify several novel scaffolds that bind ULK4 and can lead the way to more selective small molecules that may help shed light on the function of this enigmatic protein.
High-Resolution Structure and Inhibition of the Schizophrenia-Linked Pseudokinase ULK4.,Khamrui S, Ung PMU, Secor C, Schlessinger A, Lazarus MB J Am Chem Soc. 2019 Dec 17. doi: 10.1021/jacs.9b10458. PMID:31841327[3]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Lang B, Pu J, Hunter I, Liu M, Martin-Granados C, Reilly TJ, Gao GD, Guan ZL, Li WD, Shi YY, He G, He L, Stefansson H, St Clair D, Blackwood DH, McCaig CD, Shen S. Recurrent deletions of ULK4 in schizophrenia: a gene crucial for neuritogenesis and neuronal motility. J Cell Sci. 2014 Feb 1;127(Pt 3):630-40. doi: 10.1242/jcs.137604. Epub 2013 Nov, 27. PMID:24284070 doi:http://dx.doi.org/10.1242/jcs.137604
- ↑ Lang B, Pu J, Hunter I, Liu M, Martin-Granados C, Reilly TJ, Gao GD, Guan ZL, Li WD, Shi YY, He G, He L, Stefansson H, St Clair D, Blackwood DH, McCaig CD, Shen S. Recurrent deletions of ULK4 in schizophrenia: a gene crucial for neuritogenesis and neuronal motility. J Cell Sci. 2014 Feb 1;127(Pt 3):630-40. doi: 10.1242/jcs.137604. Epub 2013 Nov, 27. PMID:24284070 doi:http://dx.doi.org/10.1242/jcs.137604
- ↑ Khamrui S, Ung PMU, Secor C, Schlessinger A, Lazarus MB. High-Resolution Structure and Inhibition of the Schizophrenia-Linked Pseudokinase ULK4. J Am Chem Soc. 2019 Dec 17. doi: 10.1021/jacs.9b10458. PMID:31841327 doi:http://dx.doi.org/10.1021/jacs.9b10458
|